Abstract: The invention pertains to chimeric polypeptides of the formula:
B—X
wherein B represents the B fragment of Shiga toxin or a functional equivalent thereof, and X represents one or more polypeptides of therapeutic significance. Compositions for therapeutic use comprising the polypeptide B—X are also included.
Type:
Grant
Filed:
January 18, 2000
Date of Patent:
September 2, 2003
Assignee:
Institut Curie and Centre National de la Recherche
Scientifique